Epstein Richard J
University of New South Wales and Garvan Institute of Medical Research, Sydney, Australia.
Future Healthc J. 2023 Mar;10(1):85-89. doi: 10.7861/fhj.2022-0049.
The inequity of medical negligence-based adversarial litigation in the USA, UK and Australia is a recognised target for reform. Plaintiff autonomy is weakened by a dispute resolution system that has evolved around lawyers, opposed experts and indemnity insurers; the need to prove breach and causation excludes compensation for other categories of medical injury; and patient access to the system is restricted by high entry costs. Two strategies towards reform are raised here. A short-term approach involves routine initial use of a single court-appointed medical expert for assessment of errors and liabilities, thus improving access while relegating fault-finding to a reserve role. In the longer term, adversarial litigation could be replaced in part by a no-fault compensation scheme - such as in Scandinavia, France and New Zealand - funded by taxation and by re-directed medical indemnity fees. Reforms such as these would be challenging to implement, but are achievable, so it is not premature for relevant bodies to consider a timetable for action.
美国、英国和澳大利亚基于医疗过失的对抗性诉讼存在不公平现象,这是公认的改革目标。围绕律师、对立专家和赔偿保险公司发展起来的纠纷解决系统削弱了原告的自主权;证明存在过错和因果关系的必要性排除了对其他类型医疗伤害的赔偿;高昂的立案费用限制了患者使用该系统。本文提出了两种改革策略。短期方法包括常规性地初步使用由法院指定的单一医学专家来评估错误和责任,从而在将过错认定降至次要地位的同时改善立案机会。从长远来看,对抗性诉讼可以部分地被无过错赔偿计划所取代——比如在斯堪的纳维亚、法国和新西兰——该计划由税收和重新定向的医疗赔偿费用提供资金。诸如此类的改革实施起来具有挑战性,但并非无法实现,因此相关机构考虑制定行动时间表并不为早。